21 May 2013
Keywords: dov, closes, deal, merck, co, novel, triple
Article | 20 September 2004
DOV Pharmaceutical says it has closed a licensing deal with anaffiliate of drug major Merck & Co for the development and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 September 2004
13 September 2004
20 May 2013
© 2013 thepharmaletter.com